Securities Enforcement and Disputes and the Life Sciences Industry
Counsel and compliance professionals at life sciences companies must be prepared to identify, assess, and mitigate the potential risks to their businesses stemming from aggressive governmental investigations and private securities litigation, along with surging whistleblower activity.
This one-day, interactive program was designed to equip company counsel and compliance professionals in the life sciences industry at all levels with the tools needed to manage critical issues that arise in securities enforcement and litigation.
A team of Arnold & Porter attorneys comprised of former SEC, DOJ, and other seasoned litigators with decades of experience handling life sciences-related securities enforcement and disputes addressed the following topics:
- SEC Enforcement Developments and Trends, FCPA and Other Compliance Risks, and Recent Securities Litigation in the Life Sciences Industry
- Handling Concurrent Governmental Investigations, Internal Investigations, and Private Securities Litigation
- M&A Litigation and Commercial Disputes
- Ethics Considerations when Interacting with Current and Former Employees During Investigations and Litigation
The program also included a keynote address on crisis management by the former United States Attorney for the District of New Jersey, Paul Fishman, and a former senior member of his executive team, John Fietkiewicz.